New compound could terminate pancreatic tumours
An effective therapy for pancreatic cancer could soon be a reality as researchers have discovered a chemical compound that reduces the growth of cancerous tumours in the pancreas by 80 percent in treated mice.
The compound — MM41 — was designed to block faulty genes. It appears to do this by targeting little knots in their DNA called quadruplexes, especially found in faulty genes.